HCAT (Health Catalyst) PB Ratio: 1.04 (As of Jun. 29, 2026) — 34% Below Median


HCAT Health Catalyst Inc HCAT
44 GF Score
Price $1.94
GF Value $5.06
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Health Catalyst PB Ratio?

Health Catalyst HCAT +2.37% 44 PB Ratio is 1.04 as of Jun. 29, 2026, which is 34% below its 10-year median of 1.58. GuruFocus rates HCAT with a GF Score™ of 44/100 and a GF Value™ of $5.06 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Health Catalyst ranks better than 77.47% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), Health Catalyst's share price is $1.94. Health Catalyst's Book Value per Share for the quarter that ended in Mar. 2026 was $1.87. Hence, Health Catalyst's PB Ratio of today is 1.04.

Warning Sign:

Health Catalyst Inc stock PB Ratio (=1.01) is close to 1-year high of 1.03.

The historical rank and industry rank for Health Catalyst's PB Ratio or its related term are showing as below:

HCAT' s PB Ratio Range Over the Past 10 Years
Min: 0.32   Med: 1.58   Max: 9.63
Current: 1.04

During the past 9 years, Health Catalyst's highest PB Ratio was 9.63. The lowest was 0.32. And the median was 1.58.

HCAT's PB Ratio is ranked better than
77.47% of 608 companies
in the Healthcare Providers & Services industry
Industry Median: 1.985 vs HCAT: 1.04

During the past 12 months, Health Catalyst's average Book Value Per Share Growth Rate was -65.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -23.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -13.30% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Health Catalyst was 12.00% per year. The lowest was -23.70% per year. And the median was -8.65% per year.

Back to Basics: PB Ratio


Health Catalyst  (NAS:HCAT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Health Catalyst PB Ratio Related Terms


Health Catalyst PB Ratio Historical Data

* Premium members only.

The historical data trend for Health Catalyst's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Catalyst PB Ratio Chart

Health Catalyst Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only 3.99 1.38 1.47 1.24 0.70

Health Catalyst Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.76 0.61 0.70 0.68

HCAT vs SY, AMWL, OPRX: PB Ratio Comparison

For the Health Information Services subindustry, Health Catalyst's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's PB Ratio distribution charts can be found below:

* The bar in red indicates where Health Catalyst's PB Ratio falls into.


HCAT
44GF Score
Health Catalyst Inc HCAT
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health Catalyst PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Health Catalyst's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=1.94/1.873
=1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 1.04 mean?
Health Catalyst (HCAT) has a PB Ratio of 1.04 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Health Catalyst and its competitors. This is 34% below median its historical median of 1.58. Over the past decade, Health Catalyst's PB Ratio has ranged from 0.32 to 9.63. According to the industry distribution chart, Health Catalyst ranks #137 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 22.5%.
Is Health Catalyst's PB Ratio too high?
Health Catalyst's current PB Ratio of 1.04 is 34% below median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 9.63. The Healthcare Providers & Services industry median PB Ratio is 1.99. Health Catalyst's value of 1.04 is 47.6% below this industry median. Based on the distribution chart, Health Catalyst ranks #137 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Health Catalyst has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's PB Ratio compare to SY and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #137 out of 608 companies for PB Ratio. This places Health Catalyst in the top 23% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.99. Health Catalyst's value of 1.04 is 47.6% below this benchmark. Historically, Health Catalyst's own PB Ratio has ranged from 0.32 to 9.63 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 1.99, Health Catalyst has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current PB Ratio of 1.04 is 47.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current PB Ratio is 1.04, which is 34% below median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.06, compared to a current price of $1.94 — trading 61.7% below its estimated fair value. The current PB Ratio is 1.04, which is 34% below median its 10-year median of 1.58 and 47.6% below the Healthcare Providers & Services industry median of 1.99. Health Catalyst's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Health Catalyst (HCAT), the current PB Ratio is 1.04 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $1.94 is trading 61.7% below its estimated GF Value™ of $5.06. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

  • PB Ratio: 1.04 (34% below median its 10-year median of 1.58)
  • GF Value™: $5.06 vs. price of $1.94 (61.7% below fair value)
  • GF Score™: 44/100 with 5 warning signs
  • Industry Position: 47.6% below the Healthcare Providers & Services median (#137 of 608)

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health Catalyst Business Description

Other Exchanges 2YP:Germany
Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
44GF Score

Get the complete analysis for HCAT

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.94
Price
$5.06
GF Value